Comment
Author: Admin | 2025-04-28
Office Patent 3,470,072Patent Title: COMPOSITIONS ET PROCÉDÉS POUR MODULATION DE L'ÉPISSAGE DU SMN2 (COMPOSITIONS AND METHODS FOR MODULATION OF SMN2 SPLICING)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 1,896,002Patent Title: FORMULATIONS A LIBERATION MODIFIEE D'UN SEL DE BUPROPION (MODIFIED-RELEASE FORMULATIONS OF A BUPROPION SALT)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 2,032,124Patent Title: SYSTÈME DE DÉLIVRANCE OSMOTIQUE MULTIPARTICULAIRE (MULTIPARTICULATE OSMOTIC DELIVERY SYSTEM)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 2,185,139Patent Title: BROMHYDRATE DE BUPROPION ET APPLICATIONS THÉRAPEUTIQUES (BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 2,214,650Patent Title: BROMHYDRATE DE BUPROPIONE ET SES APPLICATIONS THÉRAPEUTIQUES (BUPROPION HYDROBROMIDE AND THERAPEUTIC APPLICATIONS)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 2,474,308Patent Title: Formulations pharmaceutiques contenant l'hydrobromure de bupropion (Pharmaceutical formulations containing bupropion hydrobromide)When can APLENZIN (bupropion hydrobromide) generic drug versions launch?Generic name: bupropion hydrobromideDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: June 27, 2025Generic Entry Controlled by: European Patent Office Patent 2,502,621Patent Title: Formes cristallines de bupropine HBr (Crystalline forms of bupropion HBr)When can BOSULIF (bosutinib monohydrate) generic drug versions launch?Generic name: bosutinib monohydrateDrugPatentWatch® Estimated Key Patent Expiration / Generic Entry Date: July 01, 2025Generic Entry Controlled by: European
Add Comment